DZ2846A1 - Forme posologique à usage oral comprenant une combinaison de metformine et de glibenclamide. - Google Patents

Forme posologique à usage oral comprenant une combinaison de metformine et de glibenclamide.

Info

Publication number
DZ2846A1
DZ2846A1 DZ990146A DZ990146A DZ2846A1 DZ 2846 A1 DZ2846 A1 DZ 2846A1 DZ 990146 A DZ990146 A DZ 990146A DZ 990146 A DZ990146 A DZ 990146A DZ 2846 A1 DZ2846 A1 DZ 2846A1
Authority
DZ
Algeria
Prior art keywords
glibenclamide
metformin
combination
dosage form
oral use
Prior art date
Application number
DZ990146A
Other languages
English (en)
French (fr)
Inventor
Yves Bonhomme
Geoffrey Nicholson
Gillian Cave
Sarah J Nicholson
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8235441&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2846(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lipha filed Critical Lipha
Application granted granted Critical
Publication of DZ2846A1 publication Critical patent/DZ2846A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DZ990146A 1998-07-15 1999-07-14 Forme posologique à usage oral comprenant une combinaison de metformine et de glibenclamide. DZ2846A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98401781A EP0974356B1 (en) 1998-07-15 1998-07-15 Tablets comprising a combination of metformin and glibenclamide

Publications (1)

Publication Number Publication Date
DZ2846A1 true DZ2846A1 (fr) 2003-12-01

Family

ID=8235441

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990146A DZ2846A1 (fr) 1998-07-15 1999-07-14 Forme posologique à usage oral comprenant une combinaison de metformine et de glibenclamide.

Country Status (27)

Country Link
US (2) US6303146B1 (id)
EP (4) EP0974356B1 (id)
JP (2) JP2002520371A (id)
KR (2) KR20040053177A (id)
CN (2) CN1486698A (id)
AP (1) AP1450A (id)
AR (2) AR013052A1 (id)
AT (1) ATE250418T1 (id)
AU (2) AU753604B2 (id)
BR (1) BR9906600A (id)
CA (1) CA2303537C (id)
DE (1) DE69818444T2 (id)
DK (1) DK0974356T3 (id)
DZ (1) DZ2846A1 (id)
ES (1) ES2206868T3 (id)
ID (1) ID25784A (id)
MA (1) MA24930A1 (id)
MY (1) MY129552A (id)
NZ (1) NZ503248A (id)
OA (1) OA11400A (id)
PT (1) PT974356E (id)
RU (2) RU2286788C2 (id)
SI (1) SI0974356T1 (id)
TW (2) TWI245632B (id)
UY (1) UY25611A1 (id)
WO (1) WO2000003742A2 (id)
ZA (1) ZA200001159B (id)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
BR0015294A (pt) * 1999-11-03 2003-07-15 Bristol Myers Squibb Co Método para tratamento da diabetes
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
FR2816840B1 (fr) 2000-11-17 2004-04-09 Flamel Tech Sa Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
FR2816841B1 (fr) * 2000-11-22 2004-02-06 Lipha Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
FR2825023B1 (fr) * 2001-05-23 2005-04-15 Flamel Tech Sa Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
US7767249B2 (en) * 2001-06-07 2010-08-03 Hewlett-Packard Development Company, L.P. Preparation of nanoparticles
US20050271737A1 (en) * 2001-06-07 2005-12-08 Chinea Vanessa I Application of a bioactive agent to a substrate
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US7879869B2 (en) 2001-07-30 2011-02-01 Mitsubishi Tanabe Pharma Corporation Drugs for ameliorating postcibal hyperglycemia
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
ITFI20010230A1 (it) * 2001-11-29 2003-05-29 Menarini Int Operations Lu Sa Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
US7183321B2 (en) * 2001-12-17 2007-02-27 Bristol-Myers Squibb Company Antidiabetic formulation and method
WO2003061643A1 (es) * 2002-01-25 2003-07-31 Laboratorios Silanes, S.A. De C.V. Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2
SI1476138T1 (sl) * 2002-02-21 2012-07-31 Valeant Internat Barbados Srl Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola
US20030187074A1 (en) * 2002-03-04 2003-10-02 Javed Hussain Oral compositions for treatment of diabetes
US20030219482A1 (en) * 2002-03-21 2003-11-27 Chaudhari Sunil Sudhakar Multiparticulate compositions for once-a-day administration
MXPA04009979A (es) 2002-04-09 2004-12-13 Flamel Tech Sa Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxicilina.
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
US7445796B2 (en) * 2002-08-19 2008-11-04 L. Perrigo Company Pharmaceutically active particles of a monomodal particle size distribution and method
WO2004045622A1 (en) * 2002-11-15 2004-06-03 Ranbaxy Laboratories Limited Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
FR2853831A1 (fr) * 2003-03-05 2004-10-22 Usv Ltd Forme posologique solide a usage oral de metformine et de glyburide et son procede de preparation
WO2004091661A1 (ja) * 2003-04-15 2004-10-28 Chugai Seiyaku Kabushiki Kaisha 糖尿病治療剤
US20060121108A1 (en) * 2004-12-02 2006-06-08 Prasad C K System and method for producing a directly compressible, high-potency formulation of metformin hydrochloride
CN100341495C (zh) * 2004-12-29 2007-10-10 三九医药股份有限公司 格列本脲固体分散体、口服组合物及其制备方法
KR100760430B1 (ko) * 2004-12-31 2007-10-04 한미약품 주식회사 당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
PE20061245A1 (es) * 2005-03-30 2007-01-06 Generex Pharm Inc Composiciones para la transmision transmucosa oral de la metformina
US8529537B2 (en) * 2005-08-05 2013-09-10 Kimberly-Clark Worldwide, Inc. Absorbent article with enclosures
MXPA05009633A (es) * 2005-09-08 2007-03-07 Silanes Sa De Cv Lab Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
EP2037928B1 (en) 2006-06-26 2012-01-11 Amgen Inc. Methods for treating atherosclerosis
WO2008062273A2 (en) * 2006-11-20 2008-05-29 Cadila Pharmaceuticals Limited Solid oral dosage form having antidiabetic drug combination
EP2185138B1 (en) 2007-07-19 2016-09-07 Takeda Pharmaceutical Company Limited Solid preparation comprising alogliptin and metformin hydrochloride
EP2489731B1 (en) 2007-07-26 2014-08-27 Amgen, Inc Modified lecithin-cholesterol acyltransferase enzymes
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
US20130108699A1 (en) * 2010-04-26 2013-05-02 Jose Antonio Matji Tuduri Highly dispersible granulate for the preparation of formulations of high dosage active substances and procedure for obtaining high dosage active substances thereof
RU2451506C1 (ru) 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
JP6635655B2 (ja) 2011-12-08 2020-01-29 アムジエン・インコーポレーテツド ヒトｌｃａｔ抗原結合タンパク質および治療法におけるそれらの使用
CN104127424A (zh) * 2014-07-30 2014-11-05 沈阳药科大学 格列本脲衍生物及其制备方法和应用
CN105030793A (zh) * 2015-08-25 2015-11-11 瑞阳制药有限公司 二甲双胍格列本脲胶囊及其制备方法
WO2019070109A1 (es) * 2017-10-03 2019-04-11 Infinite Clinical Research International, S.A. De C.V. Triconjugado para el tratamiento de diabetes mellitus
KR102484756B1 (ko) * 2020-11-13 2023-01-06 한국생산기술연구원 용해성 증대 및 취급용이성을 갖는 파우더 배지의 과립화 방법
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE362704C (de) * 1921-08-09 1922-11-02 Naamlooze Vennootschap Interna Vorrichtung zum Senken einer Last, insbesondere eines Rettungsbootes
US3174901A (en) 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
US4060634A (en) * 1973-09-26 1977-11-29 Boehringer Mannheim G.M.B.H. Rapidly resorbable glibenclamide
DE2348334C2 (de) 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
US4916163A (en) 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
DE3833439A1 (de) 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
DK36392D0 (da) 1992-03-19 1992-03-19 Novo Nordisk As Anvendelse af kemisk forbindelse
DE4323636A1 (de) 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
TW438587B (en) 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
WO1998057634A1 (en) 1997-06-18 1998-12-23 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and metformin
US6544564B1 (en) * 2001-11-27 2003-04-08 Michael Donald Farley Cytotoxic pharmaceutical composition

Also Published As

Publication number Publication date
JP2003292443A (ja) 2003-10-15
EP0974356A1 (en) 2000-01-26
RU2286788C2 (ru) 2006-11-10
CN1146427C (zh) 2004-04-21
EP1011684A2 (en) 2000-06-28
SI0974356T1 (en) 2003-12-31
EP2269613A3 (en) 2012-10-17
AU2003261560A1 (en) 2005-05-26
WO2000003742A3 (en) 2000-04-20
USRE38629E1 (en) 2004-10-19
MY129552A (en) 2007-04-30
AU753604B2 (en) 2002-10-24
EP1435240A3 (en) 2009-08-12
US6303146B1 (en) 2001-10-16
AP1450A (en) 2005-07-25
DE69818444T2 (de) 2004-05-06
TW555560B (en) 2003-10-01
KR20040053177A (ko) 2004-06-23
ZA200001159B (en) 2001-05-31
KR100478347B1 (ko) 2005-03-23
OA11400A (en) 2004-04-08
AR013052A1 (es) 2000-11-22
EP0974356B1 (en) 2003-09-24
ES2206868T3 (es) 2004-05-16
MA24930A1 (fr) 2000-04-01
PT974356E (pt) 2004-02-27
EP2269613A2 (en) 2011-01-05
DK0974356T3 (da) 2003-10-27
AP2000001757A0 (en) 2000-03-31
AR065970A2 (es) 2009-07-15
EP1435240A2 (en) 2004-07-07
JP2002520371A (ja) 2002-07-09
ID25784A (id) 2000-11-02
TW200303208A (en) 2003-09-01
AU5417999A (en) 2000-02-07
WO2000003742A2 (en) 2000-01-27
RU2003126257A (ru) 2005-02-27
CN1275082A (zh) 2000-11-29
DE69818444D1 (de) 2003-10-30
CA2303537C (en) 2005-12-06
NZ503248A (en) 2002-09-27
ATE250418T1 (de) 2003-10-15
BR9906600A (pt) 2000-07-18
CN1486698A (zh) 2004-04-07
RU2226396C2 (ru) 2004-04-10
TWI245632B (en) 2005-12-21
CA2303537A1 (en) 2000-01-27
UY25611A1 (es) 2000-08-21
KR20010030603A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
DZ2846A1 (fr) Forme posologique à usage oral comprenant une combinaison de metformine et de glibenclamide.
BR9912980B1 (pt) Composição farmacêutica administrável oralmente, tablete de mascar contendo a mesma e utilização da mesma
ID24128A (id) Dispenser dengan alat penghitung dosis
DE59903941D1 (de) Offsetdruckwerk
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
DK1051179T3 (da) Anti-estrogen- plus progestin-holdige orale kontraceptiva
BR9911123B1 (pt) compostos derivados de diàxido de benzotiepina-1,1, processo para sua preparaÇço e seu uso, medicamentos contendo-os e processo para a preparaÇço desses.
EP1368000A4 (en) CHRONOTHERAPEUTIC PHARMACEUTICAL FORMS CONTAINING A GLUCOCORTICOSTEROID
DE69830382D1 (de) Sicheres Drucken
DE69814501D1 (de) Antimikrobielle Karies anzeigende Zusammensetzung
EE200000481A (et) Angiotensiin II 2. tüüpi retseptori agonisti sisaldav farmatseutiline preparaat ja selle kasutamine
HUP0301949A3 (en) Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
FR2720230B1 (fr) Produit parasiticide contenant une combinaison synergétique de substances actives à base de pymétrozine.
DE69809682D1 (de) Lichtempfindliches Element für den Flexodruck
EE200000621A (et) Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
EE200100018A (et) Propoksilaati sisaldavad kütusesegud
DE69905968D1 (de) Eine Fotoresistzusammensetzung
ATE260659T1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
DE69830413D1 (de) Gerät für dentale abdrücke
DZ2547A1 (fr) Formes posologiques de sertraline à libération prolongée.
EE200000022A (et) Uus ravimvorm
MA25834A1 (fr) Utilisation d'une combinaison de salmeterol et de propionate de fluticasone.
FR2822409B1 (fr) Unite d'impression planetaire a neuf cylindres
TR200001362T2 (tr) Yeni karvedilol oral dozaj formu
FR2732217B1 (fr) Forme d'administration solide a usage oral